Alimera Common Stock Shares Outstanding vs Total Current Assets Analysis
ALIM Stock | USD 3.20 0.08 2.44% |
Alimera Sciences financial indicator trend analysis is way more than just evaluating Alimera Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Alimera Sciences is a good investment. Please check the relationship between Alimera Sciences Common Stock Shares Outstanding and its Total Current Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.
Common Stock Shares Outstanding vs Total Current Assets
Common Stock Shares Outstanding vs Total Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Alimera Sciences Common Stock Shares Outstanding account and Total Current Assets. At this time, the significance of the direction appears to have almost no relationship.
The correlation between Alimera Sciences' Common Stock Shares Outstanding and Total Current Assets is 0.13. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Total Current Assets in the same time period over historical financial statements of Alimera Sciences, assuming nothing else is changed. The correlation between historical values of Alimera Sciences' Common Stock Shares Outstanding and Total Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Alimera Sciences are associated (or correlated) with its Total Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Assets has no effect on the direction of Common Stock Shares Outstanding i.e., Alimera Sciences' Common Stock Shares Outstanding and Total Current Assets go up and down completely randomly.
Correlation Coefficient | 0.13 |
Relationship Direction | Positive |
Relationship Strength | Insignificant |
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Total Current Assets
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.Most indicators from Alimera Sciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Alimera Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.At this time, Alimera Sciences' Tax Provision is very stable compared to the past year. As of the 18th of May 2024, Issuance Of Capital Stock is likely to grow to about 85.1 M, while Sales General And Administrative To Revenue is likely to drop 0.22.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 5.4M | 5.9M | 10.2M | 10.7M | Depreciation And Amortization | 2.6M | 2.7M | 8.7M | 9.2M |
Alimera Sciences fundamental ratios Correlations
Click cells to compare fundamentals
Alimera Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Alimera Sciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 50.3M | 50.9M | 58.5M | 42.6M | 153.5M | 161.2M | |
Short Long Term Debt Total | 39.0M | 44.6M | 43.6M | 44.3M | 67.4M | 70.8M | |
Other Current Liab | 4.7M | 3.2M | 3.4M | 4.0M | 12.8M | 13.5M | |
Total Current Liabilities | 12.0M | 12.3M | 12.6M | 39.7M | 21.9M | 14.3M | |
Total Stockholder Equity | (4.4M) | (8.0M) | (2.6M) | (20.8M) | 46.2M | 48.5M | |
Property Plant And Equipment Net | 2.0M | 2.4M | 4.5M | 3.9M | 3.6M | 3.8M | |
Net Debt | 29.6M | 33.4M | 27.1M | 39.1M | 55.3M | 58.1M | |
Retained Earnings | (387.6M) | (392.9M) | (397.3M) | (415.4M) | (418.5M) | (439.4M) | |
Accounts Payable | 7.1M | 7.5M | 8.7M | 10.1M | 8.3M | 5.0M | |
Cash | 9.4M | 11.2M | 16.5M | 5.3M | 12.1M | 19.3M | |
Non Current Assets Total | 17.6M | 15.9M | 16.4M | 13.2M | 101.1M | 106.2M | |
Non Currrent Assets Other | (16.8M) | (15.2M) | 833K | 183K | 52K | 54.6K | |
Cash And Short Term Investments | 9.4M | 11.2M | 16.5M | 5.3M | 12.1M | 20.5M | |
Net Receivables | 19.3M | 17.2M | 19.1M | 19.6M | 34.5M | 36.3M | |
Common Stock Total Equity | 691K | 701K | 50K | 57K | 65.6K | 62.3K | |
Common Stock Shares Outstanding | 4.8M | 5.1M | 6.6M | 7.0M | 25.6M | 26.8M | |
Liabilities And Stockholders Equity | 50.3M | 50.9M | 58.5M | 42.6M | 153.5M | 161.2M | |
Non Current Liabilities Total | 42.7M | 46.5M | 48.5M | 23.7M | 85.4M | 89.7M | |
Inventory | 1.4M | 2.7M | 2.7M | 1.6M | 1.9M | 1.7M | |
Other Current Assets | 2.6M | 3.7M | 3.8M | 2.9M | 3.9M | 2.5M | |
Other Stockholder Equity | 353.8M | 366.2M | 377.2M | 378.2M | 458.6M | 286.4M | |
Total Liab | 54.8M | 58.8M | 61.1M | 63.5M | 107.4M | 58.0M | |
Property Plant And Equipment Gross | 2.0M | 2.4M | 7.9M | 3.9M | 8.0M | 8.4M | |
Total Current Assets | 32.7M | 34.9M | 42.2M | 29.4M | 52.4M | 42.4M | |
Accumulated Other Comprehensive Income | (1.1M) | (553K) | (1.8M) | (3.0M) | 1.7M | 1.8M | |
Short Term Debt | 255K | 1.7M | 489K | 25.6M | 828K | 786.6K | |
Common Stock | 50K | 57K | 69K | 70K | 524K | 329.8K | |
Other Liab | 3.0M | 3.1M | 3.6M | 2.7M | 2.4M | 2.3M | |
Long Term Debt | 38.7M | 42.4M | 43.1M | 18.7M | 64.5M | 67.7M | |
Property Plant Equipment | 1.4M | 2.0M | 1.6M | 4.5M | 5.2M | 5.4M | |
Net Tangible Assets | (27.6M) | (49.5M) | (39.5M) | (29.1M) | (26.2M) | (27.5M) | |
Other Assets | 1.2M | 734K | 1.5M | 970K | 1.1M | 1.2M | |
Good Will | 18.7M | 16.7M | 14.8M | 12.8M | 14.8M | 14.4M | |
Retained Earnings Total Equity | (399.1M) | (377.1M) | (387.6M) | (392.9M) | (353.6M) | (371.3M) | |
Long Term Debt Total | 34.6M | 38.2M | 38.7M | 42.4M | 48.8M | 51.2M | |
Capital Surpluse | 341.6M | 346.1M | 350.1M | 365.8M | 420.7M | 335.8M |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Alimera Sciences using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alimera Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Alimera Stock, please use our How to Invest in Alimera Sciences guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Alimera Stock analysis
When running Alimera Sciences' price analysis, check to measure Alimera Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alimera Sciences is operating at the current time. Most of Alimera Sciences' value examination focuses on studying past and present price action to predict the probability of Alimera Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alimera Sciences' price. Additionally, you may evaluate how the addition of Alimera Sciences to your portfolios can decrease your overall portfolio volatility.
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Alimera Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alimera Sciences. If investors know Alimera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alimera Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.84) | Revenue Per Share 3.159 | Quarterly Revenue Growth 0.875 | Return On Assets (0.01) | Return On Equity (1.59) |
The market value of Alimera Sciences is measured differently than its book value, which is the value of Alimera that is recorded on the company's balance sheet. Investors also form their own opinion of Alimera Sciences' value that differs from its market value or its book value, called intrinsic value, which is Alimera Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alimera Sciences' market value can be influenced by many factors that don't directly affect Alimera Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alimera Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Alimera Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alimera Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.